The complexation properties of three related macrocycles derived from 4,13-diaza-18-crown-6 toward lead(II) are reported. The flexible macrocycle N,N'-bis(2-aminobenzyl)-4,13-diaza-18-crown-6 (L(2)) forms stable complexes with this metal ion in the presence of different counterions (perchlorate and thiocyanate). The X-ray crystal structure of [PbL(2)](SCN)(2) indicates that, in the solid state, the lead(II) ion is eight-coordinated and fits quite well into the crown hole favoring an anti arrangement of the organic receptor, which generates a very infrequent cubic coordination polyhedron around the Pb(II) ion. In solution both complexes are fluxional and the nature of the counterion seems to affect the dynamic behavior. Ligand L(3), N,N'-bis[(2-salicylaldimino)benzyl]-4,13-diaza-18-crown-6, derives from L(2) by condensation of salicylaldehyde with the amine group of each side arm. It can be deprotonated to yield cationic complexes of formula [Pb(L(3)-H)](+) where the metal ion lies asymmetrically on the cavity of the ligand, being seven-coordinated and pushed out from the crown hole, the bibracchial lariat ether presents a syn arrangement, and one of the arms remains uncoordinated. The lead(II) ion also lies asymmetrically on the cavity of the third macrocycle (L(7)), a lateral macrobicycle incorporating a phenolyl Schiff-base spacer. Spectrophotometric titrations of L(2) and (L(3)-2H)(2)(-) with lead(II) perchlorate in acetonitrile gave values of log K[PbL(2)] = 7.7(5) and log K[Pb(L(3)-2H)] = 7.2(3), demonstrating that the stability of the lead(II) complexes with these two ligands is very similar.
No takes yet. Share an insight, caveat, or question.
Esteban‐Gómez et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: